Roth Capital analyst Scott Henry is out today with a research note on shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), following recent meeting with the company’s senior management. …
Investors in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) are having a great day. Shares of the biotech are up nearly 25% in the wake of analyst upgrade.
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that the …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) announced the launch of a new website for its expanded access program (EAP) and its planned participation at the 63rd …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported financial results …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that it …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported on the …
Apple Inc. After the bell Tuesday, tech bellwether Apple Inc.
Sarepta Therapeutics Inc (NASDAQ:SRPT) is down over 45% in pre-market trading following a negative vote by an FDA advisory panel regarding the effectiveness …